Abstract
Cancer is a chronic non-communicable disease, whose prevalence is increasing due to population aging. Approximately 50% of new cancer diagnoses occur in the population over 65 years of age, thus age is identified as a risk factor. Given the limited evidence regarding treatment schemes for chemotherapy, radiotherapy and immunotherapy in the elderly, adverse outcomes derived from toxicity in systems such as: integumentary, cardiovascular, renal or neurological have an impact in the adherence to treatment and quality of life of patients. However, these scales have not been validated in Colombia. In this first publication of the series of two publications, the objective is to describe the different types of toxicity to non-oncologists in order to provide tools for early detection of symptoms associated with toxicity secondary to treatment with chemotherapy, radiotherapy and immunotherapy in older adult patients.
| Translated title of the contribution | Toxicity in the Elderly from the Perspective of Oncogeriatrics and Palliative Care. Part 1 |
|---|---|
| Original language | Spanish |
| Journal | Universitas Médica |
| Volume | 64 |
| Issue number | 4 |
| DOIs | |
| State | Published - 31 Jan 2024 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- geriatrics
- aged
- acute toxicity
- chronic Toxicity
- chemotherapy
- radiotherapy
- immunotherapy
Fingerprint
Dive into the research topics of 'Toxicity in the Elderly from the Perspective of Oncogeriatrics and Palliative Care. Part 1'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver